Psilocybin & Psychedelic Therapies for Addiction Treatment

Introduction to Psychedelic Therapies

• 💡 Dr. Albert Garcia-Romeu, Associate Professor at Johns Hopkins, researches psychedelics in humans, focusing on psilocybin for addiction treatment.
• 🔑 Psychedelic therapies are a "package deal", combining the drug with supportive care before, during, and after administration to facilitate efficacy.
• 🧠 Key substances discussed include dissociatives like ketamine and classic psychedelics like psilocybin and LSD, which show transdiagnostic potential for various disorders.

Historical Context & Research Halt

• 📜 Psilocybin has a long history of cultural and spiritual use, documented in ancient Mayan ruins and Aztec ceremonies.
• 🔬 Modern scientific discovery began in the 1950s with Gordon Wasson's encounter with Maria Sabina and Albert Hofmann's isolation of psilocybin.
• ⚠️ The Controlled Substances Act of 1970/71 severely restricted psychedelic research, leading to a near-total decline until the late 1990s.

Risks and Clinical Considerations

• ✅ Classic psychedelics like psilocybin are not physiologically toxic and have a low risk of addiction, unlike many other substances.
• 🚨 Primary risks include cardiovascular issues, potential to induce mania or psychosis in vulnerable individuals (e.g., those with psychotic illness or bipolar disorder), and challenging experiences ("bad trips").
• 🚫 Black market drugs pose risks due to unknown dosage and composition, alongside legal penalties for use and possession.

Therapeutic Applications & Process

• 🎯 Clinical research shows promise in treating tobacco smoking cessation, alcohol use disorder, major depression, and cancer-related existential distress.
• 🛠️ The therapeutic process involves intensive screening, two trained facilitators, a preparation phase, non-directive dosing sessions (1-3 high doses in a comfortable setting), and aftercare.
• 📈 Studies indicate that high-dose psilocybin combined with therapy can lead to significant and lasting reductions in symptoms for various conditions.

Mechanisms of Action & Future Outlook

• 🧠 Psychologically, psychedelics induce altered states of consciousness and mystical experiences (e.g., feelings of unity) that correlate with positive behavioral changes.
• 🔬 Biologically, these drugs acutely increase brain activity and network communication, and post-acutely, they promote neuroplasticity and neurogenesis in areas like the hippocampus and prefrontal cortex.
• 🚀 The field is rapidly expanding, with ongoing research into opioid and cannabis use disorders and other psychedelics, anticipating clinical availability in the next five years.